Abstract: The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device comprising the same.

Abstract: An anti-inflammatory composition is disclosed. The anti-inflammatory composition is useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.

Abstract: An anti-inflammatory composition is disclosed. The anti-inflammatory composition is be useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.

Abstract: The present invention provides a novel compound having a protein kinase inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof. The compound according to the present invention, stereoisomers thereof or pharmaceutically acceptable salts thereof are effective in preventing or treating protein kinase-related diseases such as cancers, autoimmune diseases, neurological diseases, metabolic diseases, infections or the like by showing a protein kinase inhibitory activity.

Abstract: The present specification relates to a compound represented by Chemical Formula 1, an organic optoelectronic diode and a display device.

Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.

Abstract: An electroluminescent display device includes a substrate including a plurality of pixel regions; an air gap over the substrate and configured to separate the plurality of pixel regions; a first electrode in each of the plurality of pixel regions; an insulating pattern covering an edge of the first electrode; a light emitting portion on the first electrode and the insulating pattern; and a second electrode on the light emitting portion.

Abstract: An electroluminescent display device includes a substrate including first, second, and third sub-pixel regions; an interlayer insulating layer and a passivation layer each separately disposed at the first, second, and third sub-pixel regions on the substrate; a reflective electrode disposed on the passivation layer of each of the first, second, and third sub-pixel regions; first, second, and third dielectric layers disposed corresponding to the first, second, and third sub-pixel regions, respectively, on the reflective electrode; a first electrode disposed on each of the first, second, and third dielectric layers; an insulating pattern covering an edge of the first electrode; a light-emitting layer disposed on the first electrode and the insulating pattern and substantially all over the substrate including the first, second, and third sub-pixel regions; and a second electrode disposed on the light-emitting layer, wherein the first, second, and third dielectric layers have different thicknesses.

Abstract: The present invention relates to a composition for inducing cell reprogramming. The indazole derivative compound contained in the composition of the present invention shows an improved biological profile and at the same time can perform efficient cell reprogramming. In addition, unlike conventional compounds (e.g. riversine or BIO) for inducing low-molecular cell reprogramming, the indazole derivative compound of the present invention does not show cytotoxicity and thus is expected to have high growth in the market of cell therapy products when clinically applied. Conventional indazole derivative compounds have never known as a use for cell reprogramming. Compared with conventional indazole derivative compounds, the compound of the present invention has a great cell reprogramming ability while having no or little cytotoxicity.

Abstract: Provided are an electronic device and an operating method thereof. The electronic device includes: a communication interface; a processor configured to output information of at least one product while a broadcast program for advertisement or sale is being displayed, control, in response to an external input for a selection from the information output, the communication interface to access a server storing shopping broadcast content produced for advertisement or sale corresponding to the selection, and output the shopping broadcast content received from the server by using streaming. The electronic device includes an external input interface configured to receive the external input.

Abstract: An electroluminescent display device is disclosed. The disclosed electroluminescent display device includes a substrate including a plurality of pixel regions; a plurality of light emitting diodes spaced apart from each other on the substrate and each corresponding to the plurality of pixel regions, respectively; a plurality of encapsulation films respectively covering each of the light emitting diodes of the plurality of light emitting diodes, wherein the plurality of encapsulation films has a first refractive index; a first partition wall disposed between each of the encapsulation films of the plurality of encapsulation films, wherein the first partition wall corresponds to a boundary between the plurality of pixel regions and has a second refractive index lower than the first refractive index; and a color filter layer disposed on the plurality of encapsulation films and the first partition wall.

Abstract: A broadcast receiving for updating service map information by scanning the broadcast signal when signaling information included in a broadcast signal has been changed.

Abstract: A method of operating an electronic device includes: determining whether an external electronic device is connected to an access point to which the electronic device is connected; transmitting state information of the electronic device to the external electronic device connected to the access point; receiving an input corresponding to the transmitted state information of the electronic device, from the external electronic device; displaying a result corresponding to the received input on a display; and transmitting the result displayed on the display to the external electronic device.

Abstract: An aspect of the present invention provides a rectal phantom unit and a phantom device including the same, including: a holder having a penetration portion formed in a longitudinal direction thereof; a rectal simulant which is inserted to the penetration portion of the holder, includes a plurality of unit plates laminated thereon, and simulates a rectum of a body; and a film which is disposed between the rectal simulant and the holder and measures an absorbed dose of radiation irradiated to the rectal simulant.

Abstract: An anti-inflammatory composition is disclosed. The anti-inflammatory composition is be useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.

Abstract: An anti-inflammatory composition is disclosed. The anti-inflammatory composition is useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.